What is the role of budesonide in the treatment of inflammatory bowel disease (IBD)?

Updated: Apr 10, 2020
  • Author: William A Rowe, MD; Chief Editor: BS Anand, MD  more...
  • Print

Budesonide (Entocort EC), a synthetic corticosteroid, is available for Crohn disease with ileal or ileocecal involvement. [71] Budesonide has extensive first-pass metabolism, which limits systemic adverse effects. [60] However, some absorption occurs over a prolonged period of exposure. Budesonide is also less effective than other standard glucocorticosteroids for the treatment of ileal Crohn disease and has not demonstrated efficacy in maintaining therapy beyond 12 months. [91]

According to the American Gastroenterological Association (AGA) guidelines, ileal-release preparations of budesonide are indicated for the treatment of patients with mild to moderate ileal and right-sided colonic Crohn disease. [60] A newer preparation of budensonide, budesonide MMX 9 mg once daily, has demonstrated efficacy in inducing remission in mild to moderate ulcerative colitis. [92]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!